About Insect Biotechnology
Insect Biotechnology also known as yellow biotechnology in contrast to plant, animal, and industrial biotechnology. This technology discuss the techniques on insects or their cells to develop products or services for human use. Diverse businesses have found insect biotechnology to be a valuable resource, particularly for the manufacture of industrial enzymes, microbial pesticides, insect DNA, and many other chemicals. Lepidopteran cells in particular represent a competitive alternative to mammalian cells in the production of biotechnology products known as insect cells (ICs). ICs are the best choice for producing complicated proteins that require a lot of posttranslational modification out of the several techniques and expression hosts available for the manufacture of biotech products.
|Unit||Value (USD Million)|
The market for Insect Biotechnology is highly competitive with several global as well as local players in the market. The global players are trying various strategies such as product innovation and using various marketing strategies to gain a higher market share. Analyst at AMA Research estimates that France Players will contribute the maximum growth to Global Insect Biotechnology market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Oxitec (United Kingdom), Protix Biosystems (Netherlands), Algenex (Spain), InnovaFeed (France), źnsect (France), Hexafly (Ireland), Loopworm (India), Norbite (Sweden), BioPhero (Denmark) and Nutrition Technologies Group (Singapore) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are EnviroFlight Corporation (United States).
AMA Research has segmented the market of Global Insect Biotechnology market by , Application (Biochemical Recycling, Pollination, Biological Control, Pest Management, Gene Therapy and Other) and Region.
On the basis of geography, the market of Insect Biotechnology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Technique, the sub-segment i.e. Recombinant DNA Technology will boost the Insect Biotechnology market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Innovation in Tissue Engineering and Regenerative Medicines for Insect Biotechnology, Surge in Demand of Bio Fuels across the World and Uses of Artificial Intelligence and Big Data for Insect Biotechnology
Market Growth Drivers:
Surge in Demand in production of biochemical reagents, Demand in development of safer, more selective, an environmentally compatible bio pesticides and Surge in Demand in development, and production of vaccines, therapeutics, and diagnostics
Increase in the spread of certain crop diseases, Limited Knowledge about Insect Biotechnology Among Individuals and Risk of cross-pollination Associated with Insect Biotechnology
Lack of Genetic Diversity for Insect Biotechnology and Threat to the survival of certain insect species
Rapid Growth in Chemical Engineering and Infrastructure
On 20 November 2020, In a press release, the French biotech company Innovafeed writes that it has opened the world’s largest insect protein production site in Nesle, North of France. This means that black soldier fly protein for salmon can be rolled out thanks to its annual 15,000 tonnes production capacity.
To address these challenges, the Environmental Protection Agency (EPA), the U.S. Department of Agriculture (USDA), and the Food and Drug Administration (FDA) have shared responsibility for regulating agricultural biotechnology in the United States. In particular, EPA regulates pesticides created through biotechnology as a part of its regulatory jurisdiction over all pesticides marketed and used in the United States. As such, EPA has tailored its basic regulatory framework to fit the distinctive characteristics of these genetically engineered biological pesticides.
Key Target Audience
Insect Biotechnology, New Entrants and Investors, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.